2004
DOI: 10.1016/j.pupt.2004.01.002
|View full text |Cite
|
Sign up to set email alerts
|

Effect of salbutamol on smoking related cough

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
11
0
1

Year Published

2007
2007
2018
2018

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 16 publications
(12 citation statements)
references
References 16 publications
0
11
0
1
Order By: Relevance
“…Furthermore, albuterol has been shown not to inhibit cough induced by capsaicin Smith et al, 1991) or citric acid (Pounsford et al, 1985) in normal volunteers. However, in smoking-related cough, albuterol afforded significant protection (Mulrennan et al, 2004).…”
Section: E B 2 -Agonistsmentioning
confidence: 96%
“…Furthermore, albuterol has been shown not to inhibit cough induced by capsaicin Smith et al, 1991) or citric acid (Pounsford et al, 1985) in normal volunteers. However, in smoking-related cough, albuterol afforded significant protection (Mulrennan et al, 2004).…”
Section: E B 2 -Agonistsmentioning
confidence: 96%
“…In an attempt to obtain a model that has some of the elements of clinically relevant cough in normal subjects, smokers with cough have been recruited to clinical studies [162]. These subjects provide another end-point, i.e.…”
Section: Normal Volunteer Studies With Airway Inflammationmentioning
confidence: 99%
“…Clinical studies conducted to date have not managed to clearly establish whether or not b 2 -agonists attenuate cough. Indeed, although some clinical studies in normal volunteers [2] and in chronic cough associated with allergic [3] or obstructive conditions [4][5][6][7] have found a beneficial effect of b 2 -agonists, other trials have not found efficacy [8,9]. This confusion may exist, in part, due to the subjective nature of symptom scoring in comparison with objective cough monitoring, which has only recently become available, and the fact that few double-blind randomised placebo-controlled studies have been performed with cough as a primary end-point.…”
mentioning
confidence: 99%